Table 1

Study accrual by participating site

InstitutionCityCountryNumber of evaluable participants
MD Anderson Cancer CenterHoustonUSA36 (36%)
Instituto de CancerologíaMedellinColombia14 (14%)
Instituto Nacional de Enfermedades NeoplásicasLimaPerú13 (13%)
Barretos Cancer HospitalBarretosBrazil8 (8%)
Hospital ItalianoBuenos AiresArgentina6 (6%)
Instituto Brasileiro de Controle do CancerSão PauloBrazil6 (6%)
Hospital Erasto GaertnerCuritibaBrazil5 (5%)
Instituto Nacional de CancerologiaMexico CityMéxico4 (4%)
Lyndon B. Johnson Hospital/Harris HealthHoustonUSA3 (3%)
Chulalongkorn UniversityBangkokThailand1 (1%)
Royal Women’s HospitalMelbourneAustralia1 (1%)
Nebraska Methodist Health SystemOmahaUSA1 (1%)
Instituto de Ginecología de RosarioRosarioArgentina1 (1%)
Fondazione Policlinico Universitario A. Gemelli IRCCSRomeItaly1 (1%)